JAMES A GERAGHTY Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JAMES A GERAGHTY.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JAMES A GERAGHTY. JAMES A GERAGHTY is a Director in JUNIPER PHARMACEUTICALS INC ($JNP) and a Director in rEVO Biologics, Inc. ($GTCB) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in Voyager Therapeutics, Inc. ($VYGR) and a Director in Fulcrum Therapeutics, Inc. ($FULC) and a Director in Orchard Therapeutics plc ($ORTX).

Address: C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM 01702 MA

Companies in which JAMES A GERAGHTY is an Insider

Fulcrum Therapeutics, Inc.

Trading Symbol: FULC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES A GERAGHTY: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IDERA PHARMACEUTICALS, INC.

Trading Symbol: IDRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES A GERAGHTY: Director
Holdings: 104,770 shares
Current Value: $163,441
Latest Transaction: Jan 06 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

JUNIPER PHARMACEUTICALS INC

Trading Symbol: JNP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES A GERAGHTY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 15 2018
$JNP Market Capitalization: $53.67M
$JNP Previous Close: $4.97

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Orchard Therapeutics plc

Trading Symbol: ORTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES A GERAGHTY: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PIERIS PHARMACEUTICALS, INC.

Trading Symbol: PIRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES A GERAGHTY:
Holdings: 20,000 shares
Current Value: $44,000
Latest Transaction: Jun 25 2020
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

rEVO Biologics, Inc.

Trading Symbol: GTCB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES A GERAGHTY: Director
Holdings: 19,025 shares
Latest Transaction: Jan 05 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Voyager Therapeutics, Inc.

Trading Symbol: VYGR
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES A GERAGHTY: Director
Holdings: 76,588 shares
Current Value: $900,675
Latest Transaction: Jun 05 2020
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of JAMES A GERAGHTY

Sentiment: All, FULC, IDRA, JNP, ORTX, PIRS, GTCB, VYGR

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 17 2021ORTXOrchard Therapeuti ...GERAGHTY JAMES ADirectorOption ExerciseA4.7940,000191,60040,000
Jan 06 2021IDRAIDERA PHARMACEUTIC ...GERAGHTY JAMES ADirectorGrantA4.024,85119,501104,77099.9 K to 104.8 K (+4.85 %)
Oct 05 2020IDRAIDERA PHARMACEUTIC ...GERAGHTY JAMES ADirectorGrantA2.258,66619,49999,91991.3 K to 99.9 K (+9.50 %)
Jul 02 2020IDRAIDERA PHARMACEUTIC ...GERAGHTY JAMES ADirectorGrantA1.7910,89419,50091,25380.4 K to 91.3 K (+13.56 %)
Jun 25 2020PIRSPIERIS PHARMACEUTI ...GERAGHTY JAMES AOption ExerciseA3.2745,000147,15045,000
Jun 25 2020PIRSPIERIS PHARMACEUTI ...GERAGHTY JAMES AOption ExerciseA3.2745,000147,15045,000
Jun 19 2020ORTXOrchard Therapeuti ...GERAGHTY JAMES ADirectorOption ExerciseA7.8135,000273,35035,000

View all JAMES A GERAGHTY insider transactions.